Honeybees in the U.S. have developed widespread resistance to the antibiotic tetracycline, likely as a result of decades of exposure to preventive antibiotics in domesticated hives, a new study has found. In tests conducted on bees in several countries, scientists from Yale University say they identified eight tetracycline resistance genes in U.S. honeybees that were largely absent in bees found in places where the antibiotics are banned. In the U.S., the use of oxytetracycline — a compound similar to tetracycline — has been common since the 1950s to help prevent outbreaks of “foulbrood,” a bacterial disease that can devastate honeybee hives. “There’s a pattern here, where the U.S. has these genes and the other [countries] don’t,” said Nancy Moran, a lead author of the study published in the journal mBio. The authors warn that the treatment meant to prevent disease and strengthen honeybee hives in the U.S. may have actually weakened the bees’ ability to fight off other pathogens.
U.S. Honeybees Have Developed Resistance to Antibiotic, Study Says
More From E360
-
INTERVIEW
Pakistan’s Solar Revolution Is Bringing Power to the People
-
Food & Agriculture
In Uganda, Deadly Landslides Force an Agricultural Reckoning
-
Energy
Why U.S. Geothermal May Advance, Despite Political Headwinds
-
Food & Agriculture
In War Zones, a Race to Save Key Seeds Needed to Feed the World
-
Climate
Lightning Strikes the Arctic: What Will It Mean for the Far North?
-
RIVERS
A Win for Farmers and Tribes Brings New Hope to the Klamath
-
Solutions
Deconstructing Buildings: The Quest for New Life for Old Wood
-
NATURAL DEFENSES
How Restored Wetlands Can Protect Europe from Russian Invasion
-
Solutions
Birds vs. Wind Turbines: New Research Aims to Prevent Deaths
-
Biodiversity
Cambodian Forest Defenders at Risk for Exposing Illegal Logging
-
OPINION
The ‘Green’ Aviation Fuel That Would Increase Carbon Emissions
-
Solutions
Out of the Wild: How A.I. Is Transforming Conservation Science